摘要
Prevention of hepatitis B virus(HBV) infection with its consequent development of HBV chronic liver disease and hepatocellular carcinoma is a global mandatory goal. Fortunately, safe and effective HBV vaccines are currently available. Universal hepatitis B surface antigen HBV vaccination coverage is almost done. Growing knowledge based upon monitoring and surveillance ofHBV vaccination programs has accumulated and the policy of booster vaccination has been evaluated. This review article provides an overview of the natural history of HBV infection, immune responses and the future of HBV infection. It also summarizes the updated sources, types and uses of HBV vaccines, whether in the preclinical phase or in the post-field vaccination.
Prevention of hepatitis B virus (HBV) infection with itsconsequent development of HBV chronic liver diseaseand hepatocellular carcinoma is a global mandatorygoal. Fortunately, safe and effective HBV vaccines arecurrently available. Universal hepatitis B surface antigenHBV vaccination coverage is almost done. Growingknowledge based upon monitoring and surveillance of HBV vaccination programs has accumulated and thepolicy of booster vaccination has been evaluated. Thisreview article provides an overview of the natural historyof HBV infection, immune responses and the future ofHBV infection. It also summarizes the updated sources,types and uses of HBV vaccines, whether in the preclinicalphase or in the post-field vaccination.